PERSONALIS, INC. (PSNL) Announces Clinical Trial Update
PERSONALIS, INC. (PSNL) provided an update on its clinical development programs.
Clinical Development Highlights:
Collaboration: Common Stock
🔬 Clinical Development Pipeline (PERSONALIS, INC.):
Product
Type
Development Stage
Therapeutic Area
Source
Transparent Radial Artery Band (Screw-Type)
Other
Approved
Cardiac Disease
ClinicalTrials.gov
68Ga-FAPI-46-PET-CT
Other
Approved
Triple Negative Breast Cancer
ClinicalTrials.gov
ctDNA monitoring
Other
Approved
Triple Negative Breast Cancer
ClinicalTrials.gov
AZD2936
Other
Phase PHASE2
Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)
📋 PERSONALIS, INC. (PSNL) - Clinical Trial Update
Filing Date: 2026-08-20
Accepted: 2026-08-20 16:46:06
Event Type: Clinical Trial Update
Event Details:
🔬 Clinical Development Pipeline (PERSONALIS, INC.):
💼 Business Developments:
No business developments data available.
Structured Data: